RT @TaliLev123: Calvin Kuo speaks at the #AACR23 Forum on: What is the Utility of PDX and Organoid Models in the Era of Immuno-Oncology. Se…
RT @TaliLev123: Calvin Kuo speaks at the #AACR23 Forum on: What is the Utility of PDX and Organoid Models in the Era of Immuno-Oncology. Se…
RT @TaliLev123: Calvin Kuo speaks at the #AACR23 Forum on: What is the Utility of PDX and Organoid Models in the Era of Immuno-Oncology. Se…
Calvin Kuo speaks at the #AACR23 Forum on: What is the Utility of PDX and Organoid Models in the Era of Immuno-Oncology. See his beautiful @CD_AACR paper https://t.co/SrWBz0OXDu https://t.co/jbavhMOgPu
RT @TaliLev123: Amazing talks and posters at #AACRepigen22 about SWI/SNF. See the @CD_AACR paper by Calvin Kuo: A CRISPR/Cas9-Engineered…
RT @TaliLev123: Amazing talks and posters at #AACRepigen22 about SWI/SNF. See the @CD_AACR paper by Calvin Kuo: A CRISPR/Cas9-Engineered…
Amazing talks and posters at #AACRepigen22 about SWI/SNF. See the @CD_AACR paper by Calvin Kuo: A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation https://t.
RT @TaliLev123: Beautiful and inspiring presentation by Calvin Kuo including this CD_AACR paper and exciting developments in the organoids…
Beautiful and inspiring presentation by Calvin Kuo including this CD_AACR paper and exciting developments in the organoids field 👇 #AACR22
RT @ElizSMcKenna: At the AACR-JCA Joint Session on #Organoids at #AACR22? ICYMI in @CD_AACR by speaker Calvin Kuo @StanfordMed: A CRISPR/Ca…
RT @ElizSMcKenna: At the AACR-JCA Joint Session on #Organoids at #AACR22? ICYMI in @CD_AACR by speaker Calvin Kuo @StanfordMed: A CRISPR/Ca…
At the AACR-JCA Joint Session on #Organoids at #AACR22? ICYMI in @CD_AACR by speaker Calvin Kuo @StanfordMed: A CRISPR/Cas9-Engineered #ARID1A-deficient Human #GastricCancer Organoid Model Reveals Essential & Non-Essential Modes of Oncogenic Transforma
RT @SCIDirector: SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsupp…
RT @SCIDirector: SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsupp…
RT @SCIDirector: SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsupp…
RT @SCIDirector: SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsupp…
RT @SCIDirector: SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsupp…
SCI member Calvin Kuo and colleagues established the first human forward genetic modeling of a commonly mutated #tumorsuppressor gene, ARID1A, using a #CRISPRCas9 engineered #gastriccancer #organoid model. https://t.co/KnVHaP7tkS @CD_AACR
RT @dow_lab: With @Yess_Indeed, very happy to summarize a recent paper from Yuan-Hung Lo and Calvin Kuo on ARID1A function in gastric cance…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
From the June issue: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential and non-essential modes of oncogenic transformation. @StanfordMed https://t.co/Zj21o8Trpd https://t.co/aEbgFc2VO0
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @dow_lab: With @Yess_Indeed, very happy to summarize a recent paper from Yuan-Hung Lo and Calvin Kuo on ARID1A function in gastric cance…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
RT @DRSNmoonshot: Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commo…
Dr. Calvin Kuo @DRSNmoonshot & team @StanfordMed demonstrate @CD_AACR the first human forward genetic modeling of a commonly mutated tumor suppressor gene, ARID1A using organoids, to reveal essential & non essential modes of oncogenic transformatio
RT @dow_lab: With @Yess_Indeed, very happy to summarize a recent paper from Yuan-Hung Lo and Calvin Kuo on ARID1A function in gastric cance…
RT @dow_lab: With @Yess_Indeed, very happy to summarize a recent paper from Yuan-Hung Lo and Calvin Kuo on ARID1A function in gastric cance…
With @Yess_Indeed, very happy to summarize a recent paper from Yuan-Hung Lo and Calvin Kuo on ARID1A function in gastric cancer initiation. Their paper: https://t.co/3mgqvm9Szn
Prepare for the #AACR21 Etiology and Prevention of Upper Gastrointestinal Cancer session by reading the recent @CD_AACR paper on ARID1A-deficient human gastric cancer organoids by Calvin Kuo @Stanford and colleagues with your ☕️ https://t.co/kXAh14czBj
RT @TaliLev123: Watching the Methods Workshop: Organoid Cultures to Study Cancer at #AACR21? ICYMI in @CD_AACR: A CRISPR/Cas9-engineered AR…
RT @TaliLev123: Watching the Methods Workshop: Organoid Cultures to Study Cancer at #AACR21? ICYMI in @CD_AACR: A CRISPR/Cas9-engineered AR…
RT @TaliLev123: Watching the Methods Workshop: Organoid Cultures to Study Cancer at #AACR21? ICYMI in @CD_AACR: A CRISPR/Cas9-engineered AR…
RT @TaliLev123: Watching the Methods Workshop: Organoid Cultures to Study Cancer at #AACR21? ICYMI in @CD_AACR: A CRISPR/Cas9-engineered AR…
Watching the Methods Workshop: Organoid Cultures to Study Cancer at #AACR21? ICYMI in @CD_AACR: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential and non-essential modes of oncogenic transformation https://t.c
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
Today's read 71 #Organoids Gastric cancer #organoid @CD_AACR A CRISPR/Cas9-engineered #ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation https://t.co/rJgW03kw9I
Read the work being presented now in the Developing and Applying Preclinical Cancer Models Minisymposium at #AACR21 by Yuan-Hung Lo @StanfordMed https://t.co/JXRWeEz8iv
RT @SCIDirector: SCI member Calvin Kuo and colleagues found #CRISPR/Cas9-engineered ARID1A-deficient human gastric organoids enabled a func…
RT @SCIDirector: SCI member Calvin Kuo and colleagues found #CRISPR/Cas9-engineered ARID1A-deficient human gastric organoids enabled a func…
RT @SCIDirector: SCI member Calvin Kuo and colleagues found #CRISPR/Cas9-engineered ARID1A-deficient human gastric organoids enabled a func…
RT @SCIDirector: SCI member Calvin Kuo and colleagues found #CRISPR/Cas9-engineered ARID1A-deficient human gastric organoids enabled a func…
SCI member Calvin Kuo and colleagues found #CRISPR/Cas9-engineered ARID1A-deficient human gastric organoids enabled a functional deconstruction of essential versus non-essential mechanisms of early ARID1A-dependent tumorigenesis. https://t.co/J6CfwbkRgQ #g
Congrats to Drs. Yuhong Du and @HaianFu whose 3D organoid screening helped establish a new oncogenic transformation model of stomach cancer! Out now in @CD_AACR Read more here: https://t.co/R1dxYfqfmE
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @Intestinal_Cell: Published in @CD_AACR: A CRISPR/Cas9-engineered ARID1A-deficient human #GastricCancer organoid model reveals essentia…
Published in @CD_AACR: A CRISPR/Cas9-engineered ARID1A-deficient human #GastricCancer organoid model reveals essential and non-essential modes of oncogenic transformation. https://t.co/r816bYhjof https://t.co/XcUlaalSle
RT @NatRevClinOncol: CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals a potential vulnerability of gastr…
RT @NatRevClinOncol: CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals a potential vulnerability of gastr…
RT @NatRevClinOncol: CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals a potential vulnerability of gastr…
RT @NatRevClinOncol: CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals a potential vulnerability of gastr…
CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals a potential vulnerability of gastric cancer subsets to inhibition of BIRC5/survivin: https://t.co/pB7FqYoqYC #stcsm
RT @organoidscience: In this study, #CRISPR/Cas9-mediated ARID1A knockout in primary TP53-/- human gastric #organoids induced morphologic d…
RT @organoidscience: In this study, #CRISPR/Cas9-mediated ARID1A knockout in primary TP53-/- human gastric #organoids induced morphologic d…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @organoidscience: In this study, #CRISPR/Cas9-mediated ARID1A knockout in primary TP53-/- human gastric #organoids induced morphologic d…
In this study, #CRISPR/Cas9-mediated ARID1A knockout in primary TP53-/- human gastric #organoids induced morphologic dysplasia, tumorigenicity and mucinous differentiation. @CD_AACR 📌 Abstract https://t.co/qsCbfqM1dA 📌 PDF https://t.co/Y4hypYHTnh https:/
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
RT @CD_AACR: Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential…
Just published #OnlineFirst: A CRISPR/Cas9-engineered ARID1A-deficient human #gastriccancer #organoid model reveals essential and non-essential modes of oncogenic transformation. @StanfordMed https://t.co/008JsvigKp https://t.co/sLvNQtsOh9